Chronic News and Research

RSS

SANUWAVE Health announces completion of patient enrollment in dermaPACE Phase III clinical trial

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, today announced that patient enrollment was completed in March in its dermaPACE™ Phase III pivotal, randomized, double-blinded, sham controlled, multicenter clinical trial comparing its Pulsed Acoustic Cellular Expression technology, utilizing the dermaPACE™ tissue regeneration device, to sham control for the treatment of diabetic foot ulcers.

6 Apr 2010

Health care reform will have negative effect on cardiology patients, practices: American cardiologists

American cardiologists believe that recently passed health care reform will have a negative effect on both their cardiology patients and their practices, according to a new survey.

6 Apr 2010

Nanoparticle-core polymer holds promise as weight-bearing replacement for traditional graft materials

Orthopedic surgeons are often hamstrung by less-than-ideal grafting material when performing surgeries for complex bone injuries resulting from trauma, aging or cancer. Conventional synthetic bone grafts are typically made of stiff polymers or brittle ceramics, and cannot readily conform to the complex and irregular shapes that often result from injury; in addition, they often require metallic fixation devices that require open surgeries to insert and remove.

6 Apr 2010

ITI to lead multi-university consortium to improve patient outcomes

The U.S. health care community has increasingly been adopting the use of electronic medical records and other electronic health information systems, but serious concerns about the security and privacy of those systems have been raised.

6 Apr 2010

Next phase of health reform in the U.S. to focus on individualized care: PwC

The next phase of health reform in the United States will reflect a concerted effort to keep people well, out of the hospital and more actively engaged in managing their own health, according to PricewaterhouseCoopers LLP.

6 Apr 2010

Electronic nose may help identify asthma in patients: CHEST

New evidence shows that an "electronic nose" containing an array of gas sensors may have the ability to identify asthma in patients. Researchers from Italy compared the diagnostic performance of the electronic nose with lung function tests and fraction of exhaled nitric oxide in seven patients with asthma and seven healthy subjects.

6 Apr 2010

Dry-mouth and dry-eye symptoms often misdiagnosed by healthcare professionals

Results from a recent survey of 400 Sjogren's syndrome patients showed that half of those surveyed experienced common symptoms such as dry mouth or dry eyes for three or more years before receiving an accurate diagnosis from a healthcare professional.

6 Apr 2010

Healthcare groups to rollout two new PHR Quick Reference Guides

Several groups across the healthcare sector will rollout two new "Personal Health Record Quick Reference Guides" in an effort to educate consumers and clinicians about how PHRs can be useful tools for making more informed healthcare decisions and enhancing care coordination.

6 Apr 2010

New muco-adhesive patch may help treat oral disorders

A newly developed time-released muco-adhesive patch for treating oral health conditions, including the widespread condition of dry mouth (xerostomia), has been shown to be more effective than a leading oral rinse, according to a newly-published study.

6 Apr 2010

Alpha cells in pancreas can convert into insulin-producing beta cells: Study

Alpha cells in the pancreas, which do not produce insulin, can convert into insulin-producing beta cells, advancing the prospect of regenerating beta cells as a cure for type 1 diabetes. The findings come from a study at the University of Geneva, co-funded by the Juvenile Diabetes Research Foundation, that is published today in the online edition of the scientific journal Nature.

6 Apr 2010

World Health Day to focus on making cities healthier

As part of this year's World Health Day, the WHO on Wednesday will launch a program to encourage cities to become more healthy to help mitigate the health risks associated with rapid urbanization, Agence France Presse/Inquirer.net Global Nation reports.

6 Apr 2010

Dalfampridine drug for multiple sclerosis now available in the U.S.

A drug whose clinical benefit in treating multiple sclerosis was discovered at Rush University Medical Center was approved by the Food and Drug Administration on January 22 and is now available in the U.S.

6 Apr 2010

Economic burden associated with HAE treatment: First-ever comprehensive examination

Dyax Corp. announced the publication of a first-ever comprehensive examination of the economic burden associated with the treatment of acute attacks and chronic management of hereditary angioedema (HAE). The results, published today in the Annals of Allergy, Asthma, and Immunology, bring to light the substantial direct and indirect medical costs of the disease on patients, payers and society. The economic study is one component of a larger survey-based Burden of Illness (BOI) study which assessed both the economic and humanistic burden of HAE.

5 Apr 2010

Study: Reduced birth weight may lower risk of obesity later in life

According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism, regular moderate-intensity aerobic exercise led to a modest reduction in offspring birth weight without restricting the development of maternal insulin resistance.

5 Apr 2010

Are Australians popping too many pills?

These reports have emerged from a Daily Telegraph investigation. Australian Medical Association vice president, GP and former Pharmaceutical Benefits Advisory Committee member Dr Steve Hambleton said the resons for these trends may include the increasing population of the aged, newer medicines as well as a rise in chronic lifestyle ailments like diabetes and high blood pressure.

5 Apr 2010

Clinical utility and pharmacological action of MN-166 in treatment of MS

MediciNova, Inc, a biopharmaceutical company publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today reported that this week's issue of Neurology includes two articles related to the potential clinical utility and unique pharmacological action of MN-166 in treating multiple sclerosis (MS).

3 Apr 2010

Study: Trial vaccine eliminates residual cancer cells in CML patients

Johns Hopkins Kimmel Cancer Center researchers say preliminary studies show that a vaccine made with leukemia cells may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Imatinib mesylate (Gleevec).

3 Apr 2010

Growing problem of prescription drug abuse

Prescription painkiller abuse is a rapidly growing and widespread problem, recently coming into full view due to high profile stories and tragic celebrity deaths.

3 Apr 2010

Research Roundup: Soda taxes, health reform timeline, children's health disparities, best hospital practices

Health Affairs: Soda Taxes, Soft Drink Consumption, And Children's Body Mass Index - "Using data on state sales taxes for soda and individual-level data on children," the authors report existing taxes on soda fail to "substantially affect overall levels of soda consumption or obesity rates." However, the authors also found "statistically significant and substantively larger effects of differential soda sales taxes among children who are heavier, have lower family income, are African American, or watch a great deal of TV.

3 Apr 2010

Study highlights need for public education on osteoporosis risk factors and treatment

Underscoring what researchers call a serious international public health concern, results from the Global Longitudinal Study of Osteoporosis in Women (GLOW) showed that among women at an elevated level of risk for osteoporosis-associated fractures, there is a failure to perceive the implications of having important risk factors.

3 Apr 2010